Published in Infect Immun on July 01, 1974
Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun (1976) 1.44
Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine. Infect Immun (1975) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans. Infect Immun (1978) 1.13
T lymphocyte function as the principal target of lymphocytic choriomeningitis virus-induced immunosuppression. Infect Immun (1975) 1.06
Cell-mediated immunity in patients on long-term haemodialysis. Clin Exp Immunol (1975) 1.06
Nonspecific suppressive effect of bovine herpesvirus type 1 on bovine leukocyte functions. Infect Immun (1983) 0.99
Immunosuppression and isolation of rubella virus from human lymphocytes after vaccination with two rubella vaccines. Infect Immun (1979) 0.98
Indirect blastogenesis of peripheral blood leukocytes in experimental gingivitis. Infect Immun (1976) 0.95
Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect Immun (1995) 0.95
Cell-mediated immunity in humans during viral infection: dermal hypersensitivity and in vitro lymphocyte proliferation during mild viral respiratory infections. Infect Immun (1974) 0.91
Influenza in ferrets and guinea pigs: effect on cell-mediated immunity. Infect Immun (1978) 0.88
Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination. Can Med Assoc J (1977) 0.82
Immunosuppressive effects of Centipeda periodontii: selective cytotoxicity for lymphocytes and monocytes. Infect Immun (1987) 0.82
Amphotericin B and 5-fluorocytosine: in vitro effects on lymphocyte function. Antimicrob Agents Chemother (1978) 0.81
Lymphocyte response to T-cell mitogen during experimental gingivitis in humans. Infect Immun (1976) 0.81
Variable effect of encephalomyocarditis virus on host defense mechanisms. Infect Immun (1978) 0.80
Amphotericin B and 5-fluorocytosine: effects on cell-mediated immunity. Clin Exp Immunol (1980) 0.79
Immunosuppression and alterations of T-lymphocyte subpopulations after rubella vaccination. Infect Immun (1980) 0.79
Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C. J Clin Microbiol (1992) 0.78
Suppression of tuberculin hypersensitivity during influenza infection in mice. Infect Immun (1979) 0.76
Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med (1972) 24.43
Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest (1973) 4.69
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
EFFECTS OF MEASLES, GAMMA-GLOBULIN-MODIFIED MEASLES AND VACCINE MEASLES ON THE TUBERCULIN TEST. N Engl J Med (1964) 3.03
Immunodepression by mammalian viruses and plasmodia. Proc R Soc Med (1970) 2.43
Measurement of rubella antibody by hemagglutination inhibition. II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum. J Immunol (1970) 2.33
Effect of measles vaccine on immunologic responsiveness. Pediatrics (1969) 2.08
Phytohaemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature (1967) 1.99
Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82
Decreased skin-test reactivity associated with influenza. J Infect Dis (1972) 1.74
Studies of peripheral blood T-and B-lymphocytes in acute infections. Infect Immun (1974) 1.58
Depression of tuberculin delayed hypersensitivity by live attenuated mumps virus. J Pediatr (1970) 1.34
Surface markers on lymphocytes of patients with infectious diseases. Infect Immun (1973) 1.21
Depression of established delayed hepersensitivity by mumps virus. J Immunol (1972) 1.16
Evidence for a macrophage-mediated effect of poliovirus on the lymphocyte response to phytohemagglutinin. J Immunol (1973) 1.09
In vitro studies of the response of hamster lymphocytes to phytohemagglutinin and antigenic stimulation. J Immunol (1971) 1.06
Lymphoblast proliferation and humoral antibody response after rubella vaccination. Clin Exp Immunol (1973) 1.03
Some effects of rubella vaccination of immunologic responsiveness. Acta Paediatr Scand (1972) 0.99
Rubella: recent laboratory and clinical advances. Prog Med Virol (1966) 0.98
Immune competence in congenital rubella: lymphocyte transformation, delayed hypersensitivity, and response to vaccination. J Pediatr (1968) 0.96
Effect of HPV-80 rubella vaccine on the tuberculin reaction. Am J Dis Child (1969) 0.91
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis (1999) 9.81
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med (1996) 7.60
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med (1987) 5.74
Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med (1999) 5.18
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis (1991) 3.88
Antimicrobial treatment of pertussis. J Pediatr (1969) 3.77
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis (2000) 3.73
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med (1994) 3.32
The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med (1992) 3.32
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol (1994) 3.05
Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.03
A method for measurement of antibiotics in human interstitial fluid. J Infect Dis (1972) 2.99
Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med (1995) 2.66
The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest (1995) 2.65
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60
Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med (1990) 2.56
Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol (1995) 2.54
Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2001) 2.51
A modified assay of neutrophil function: use of lysostaphin to differentiate defective phagocytosis from impaired intracellular killing. J Lab Clin Med (1971) 2.40
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis (2001) 2.25
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1988) 2.18
Some salient features of Staphylococcus aureus endocarditis. Am J Med (1973) 2.17
Use of pertussis vaccine in an epidemic involving hospital staff. Lancet (1975) 2.15
Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol (1999) 2.11
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis (2007) 2.09
In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin. Appl Microbiol (1969) 2.09
Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis (1996) 2.09
Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 2.08
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. J Infect Dis (1994) 2.04
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol (1990) 1.90
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet (1991) 1.89
The carrier state in pertussis. Am J Epidemiol (1968) 1.86
Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1987) 1.85
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS (2001) 1.84
Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother (1996) 1.83
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. AIDS (2001) 1.79
Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol (1994) 1.79
Pertussis: persistent problems. J Pediatr (1974) 1.69
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquir Immune Defic Syndr (1993) 1.67
Comparison of CD4 cell count by a simple enzyme-linked immunosorbent assay using the TRAx CD4 test kit and by flow cytometry and hematology. Clin Diagn Lab Immunol (1995) 1.66
Bacteremia due to methicillin-resistant Staphylococcus aureus. J Infect Dis (1982) 1.64
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin Pharmacol Ther (1997) 1.64
Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous. J Infect Dis (1988) 1.60
Bordetella parapertussis. Recent experience and a review of the literature. Am J Dis Child (1977) 1.60
Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med (1978) 1.57
Disclosure of HIV antibody status: behavioral and mental health correlates. AIDS Educ Prev (1989) 1.57
Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis (1994) 1.55
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses (1990) 1.53
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Purulent pneumococcal pericarditis. A continuing problem in the antibiotic era. Am J Med (1973) 1.51
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients. Arch Intern Med (1987) 1.49
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid. Chest (1994) 1.48
Torulopsis glabrata renal infection. Am J Med (1974) 1.48
Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1994) 1.47
Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother (1990) 1.45
Risk factors for colonization with yeast species in a Veterans Affairs long-term care facility. J Am Geriatr Soc (1998) 1.45
Pathogenesis of varicella-zoster angiitis in the CNS. Arch Neurol (1980) 1.45
Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J Virol (1998) 1.44
Intermittent urethral catheterization in the elderly. J Am Geriatr Soc (1989) 1.43
Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr (1994) 1.43
Detection and characterization of mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1993) 1.43
Herpes simplex virus associated with recurrent Stevens-Johnson syndrome. A management strategy. Arch Intern Med (1992) 1.43
Yersinia enterocolitica infections in hospitalized patients: the problem of hospital-acquired infections. Infect Control Hosp Epidemiol (1992) 1.43
Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol (1996) 1.42
Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob Agents Chemother (1977) 1.42
Group B streptococcal prosthetic joint infection following sigmoidoscopy. Clin Infect Dis (1992) 1.42
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA (1994) 1.41
Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother (1992) 1.40
Transmission of herpes-simplex virus type 1 in a nursery for the newborn. Identification of viral isolates by D.N.A. "fingerprinting". Lancet (1978) 1.40
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. AIDS Res Hum Retroviruses (1990) 1.39
Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol (1987) 1.37
Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1995) 1.37
Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control (1987) 1.36
Cryptococcus laurentii lung abscess. Am Rev Respir Dis (1981) 1.35
Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1987) 1.33
The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med (1982) 1.32
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32